+Follow
FlexK
No personal profile
7
Follow
1
Followers
0
Topic
0
Badge
Posts
Hot
FlexK
2021-05-04
Dropping down trend
After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading
FlexK
2021-03-15
NIO go
Better Buy: NIO vs. XPeng Motors
FlexK
2021-03-11
???
Toplines Before US Market Open on Thursday
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":3575445316557349,"uuid":"3575445316557349","gmtCreate":1612351620583,"gmtModify":1615429049906,"name":"FlexK","pinyin":"flexk","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/5218345f4899882a5ef1356407aa5eb5","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":7,"tweetSize":3,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.07","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":106493859,"gmtCreate":1620137561771,"gmtModify":1704339180265,"author":{"id":"3575445316557349","authorId":"3575445316557349","name":"FlexK","avatar":"https://static.tigerbbs.com/5218345f4899882a5ef1356407aa5eb5","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Dropping down trend","listText":"Dropping down trend","text":"Dropping down trend","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/106493859","repostId":"1157490418","repostType":4,"repost":{"id":"1157490418","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1620120727,"share":"https://www.laohu8.com/m/news/1157490418?lang=&edition=full","pubTime":"2021-05-04 17:32","market":"us","language":"en","title":"After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1157490418","media":"Tiger Newspress","summary":"(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.What happenedShares ","content":"<p style=\"text-align:left;\">(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.</p><p><img src=\"https://static.tigerbbs.com/231cd8867b2a322ce48be7afd711946c\" tg-width=\"633\" tg-height=\"479\" referrerpolicy=\"no-referrer\"><b>What happened</b></p><p>Shares of <b>Ocugen</b>(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.</p><p><b>So what</b></p><p>Researchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.</p><p>\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"</p><p><b>Now what</b></p><p>Musunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter surging nearly 24% yesterday, OCGN dipped 4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-05-04 17:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p style=\"text-align:left;\">(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.</p><p><img src=\"https://static.tigerbbs.com/231cd8867b2a322ce48be7afd711946c\" tg-width=\"633\" tg-height=\"479\" referrerpolicy=\"no-referrer\"><b>What happened</b></p><p>Shares of <b>Ocugen</b>(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.</p><p><b>So what</b></p><p>Researchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.</p><p>\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"</p><p><b>Now what</b></p><p>Musunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157490418","content_text":"(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.What happenedShares of Ocugen(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.So whatResearchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"Now whatMusunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.","news_type":1},"isVote":1,"tweetType":1,"viewCount":191,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":322132524,"gmtCreate":1615781774768,"gmtModify":1704786399525,"author":{"id":"3575445316557349","authorId":"3575445316557349","name":"FlexK","avatar":"https://static.tigerbbs.com/5218345f4899882a5ef1356407aa5eb5","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"NIO go","listText":"NIO go","text":"NIO go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/322132524","repostId":"1161179297","repostType":4,"repost":{"id":"1161179297","pubTimestamp":1615771321,"share":"https://www.laohu8.com/m/news/1161179297?lang=&edition=full","pubTime":"2021-03-15 09:22","market":"us","language":"en","title":"Better Buy: NIO vs. XPeng Motors","url":"https://stock-news.laohu8.com/highlight/detail?id=1161179297","media":"Motley Fool","summary":"The Chinese electric-vehicle makers both have rich valuations, even after a downturn in share prices.Stocks of electric-vehicle makers accelerated in 2020. And it's no secret that Chinese EV stocks were some of the most popular, as the largest automotive market in the world continues to move toward electrification in its transportation sector.EV sales in China surpassed 1 million in 2020, and the government hopes to grow that to 5 million by 2025. It could reach 10 million by 2030, and approach","content":"<p>The Chinese electric-vehicle makers both have rich valuations, even after a downturn in share prices.</p>\n<p>Stocks of electric-vehicle (EV) makers accelerated in 2020. And it's no secret that Chinese EV stocks were some of the most popular, as the largest automotive market in the world continues to move toward electrification in its transportation sector.</p>\n<p>EV sales in China surpassed 1 million in 2020, and the government hopes to grow that to 5 million by 2025. It could reach 10 million by 2030, and approach 20 million by 2040, according to research organization BloombergNEF. Two electric automakers looking to capitalize on that expansion are <b>NIO</b> (NYSE:NIO) and <b>XPeng</b> (NYSE:XPEV). Investors may be wondering which is the better buy, particularly after a correction has hit share prices in the sector.</p>\n<p><b>The right market</b></p>\n<p>As noted above, the largest automotive market in the world has much potential forEV growth. The problem is, there will be plenty of companies seeking to capitalize.<b>Tesla</b> (NASDAQ:TSLA) built its second manufacturing plant in Shanghai for a reason. And though they're maybe the most well-known Chinese EV makers, NIO and XPeng combined delivered only slightly more than half the 131,000 battery-electric vehicles that <b>BYD</b> (OTC:BYDDY) sold in 2020.</p>\n<p>NIO reached almost 44,000 vehicles delivered in 2020, while XPeng more than doubled its volume versus 2019 to 27,041. Both companies have recently introduced sedan models that each hopes will be significant drivers of future sales growth.</p>\n<p>XPeng's P7 sports sedan has surpassed a total of 20,000 cumulative deliveries since its launch in early 2020, as it moves ahead of the G3 compact SUV as the company's most popular vehicle. That marked the fastest pace to 20,000 vehicle deliveries of any Chinese EV start-up.</p>\n<p>NIO introduced its new ET7 luxury sedan earlier this year. The ET7 will be available early next year, and has some intricate features. The sleek exterior includes autonomous driving sensors, a \"crystal-like heartbeat\" tail light, all-glass roof, and a digital entry system that extends the flush handle and automatically releases the door's \"e-latch\" as the driver approaches.</p>\n<p><b>Priced for perfection</b></p>\n<p>The strong sales growth along with massive potential for Chinese EVs had investors already piling into these stocks. But after shares of both NIO and XPeng soared last year, the stocks are off January 2021 highs by 27% and 38% respectively, making now a good time to see which may be the better buy.</p>\n<p>Neither company is profitable yet, so one way to measure valuations is using sales rather than earnings. The price-to-sales ratios (P/S) are both very high, but sales are expected to grow quickly, and it's a relevant metric for comparing the two companies.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/cf721bd77e4fa0e2530b3d2f86034920\" tg-width=\"720\" tg-height=\"483\"><span>NIO MARKET CAP DATA BY YCHARTS</span></p>\n<p>Though NIO has the higher market cap, it is less expensive than XPeng as measured by the P/S ratio. NIO also has a unique approach to the market with its battery swap program, which allows customers to \"recharge\" via a faster battery exchange. The company says its automated battery swap stations take only three minutes to produce a fully charged battery replacement.</p>\n<p><b>Looking ahead</b></p>\n<p>NIO's push into the luxury sedan segment with its ET7 could help advance the company to the next level. Gross margins, gross profit, and operating cash flow went positive in 2020, indicating the path to profitability is in sight.</p>\n<p>Both companies look to be adequately capitalized to fund planned growth efforts. As of Dec. 31, 2020, NIO had $6.5 billion in cash and cash equivalents, restricted cash, and short-term investment on its balance sheet, and XPeng had about $5.4 billion. The companies could raise more money by listing on the Hong Kong Stock Exchange, which is reportedly being considered by both.</p>\n<p>For investors looking to pick just one holding to participate in Chinese EV growth, NIO appears to be the better option of these two companies. Any investment still belongs in the speculative portion of a portfolio, with the potential for much volatility. But for those who can stomach that, and have an appropriate portion invested, the recent drop in shares helps make NIO a better buy than XPeng right now.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Better Buy: NIO vs. XPeng Motors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBetter Buy: NIO vs. XPeng Motors\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-15 09:22 GMT+8 <a href=https://www.fool.com/investing/2021/03/14/better-buy-nio-vs-xpeng-motors/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Chinese electric-vehicle makers both have rich valuations, even after a downturn in share prices.\nStocks of electric-vehicle (EV) makers accelerated in 2020. And it's no secret that Chinese EV ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/14/better-buy-nio-vs-xpeng-motors/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来","XPEV":"小鹏汽车"},"source_url":"https://www.fool.com/investing/2021/03/14/better-buy-nio-vs-xpeng-motors/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161179297","content_text":"The Chinese electric-vehicle makers both have rich valuations, even after a downturn in share prices.\nStocks of electric-vehicle (EV) makers accelerated in 2020. And it's no secret that Chinese EV stocks were some of the most popular, as the largest automotive market in the world continues to move toward electrification in its transportation sector.\nEV sales in China surpassed 1 million in 2020, and the government hopes to grow that to 5 million by 2025. It could reach 10 million by 2030, and approach 20 million by 2040, according to research organization BloombergNEF. Two electric automakers looking to capitalize on that expansion are NIO (NYSE:NIO) and XPeng (NYSE:XPEV). Investors may be wondering which is the better buy, particularly after a correction has hit share prices in the sector.\nThe right market\nAs noted above, the largest automotive market in the world has much potential forEV growth. The problem is, there will be plenty of companies seeking to capitalize.Tesla (NASDAQ:TSLA) built its second manufacturing plant in Shanghai for a reason. And though they're maybe the most well-known Chinese EV makers, NIO and XPeng combined delivered only slightly more than half the 131,000 battery-electric vehicles that BYD (OTC:BYDDY) sold in 2020.\nNIO reached almost 44,000 vehicles delivered in 2020, while XPeng more than doubled its volume versus 2019 to 27,041. Both companies have recently introduced sedan models that each hopes will be significant drivers of future sales growth.\nXPeng's P7 sports sedan has surpassed a total of 20,000 cumulative deliveries since its launch in early 2020, as it moves ahead of the G3 compact SUV as the company's most popular vehicle. That marked the fastest pace to 20,000 vehicle deliveries of any Chinese EV start-up.\nNIO introduced its new ET7 luxury sedan earlier this year. The ET7 will be available early next year, and has some intricate features. The sleek exterior includes autonomous driving sensors, a \"crystal-like heartbeat\" tail light, all-glass roof, and a digital entry system that extends the flush handle and automatically releases the door's \"e-latch\" as the driver approaches.\nPriced for perfection\nThe strong sales growth along with massive potential for Chinese EVs had investors already piling into these stocks. But after shares of both NIO and XPeng soared last year, the stocks are off January 2021 highs by 27% and 38% respectively, making now a good time to see which may be the better buy.\nNeither company is profitable yet, so one way to measure valuations is using sales rather than earnings. The price-to-sales ratios (P/S) are both very high, but sales are expected to grow quickly, and it's a relevant metric for comparing the two companies.\nNIO MARKET CAP DATA BY YCHARTS\nThough NIO has the higher market cap, it is less expensive than XPeng as measured by the P/S ratio. NIO also has a unique approach to the market with its battery swap program, which allows customers to \"recharge\" via a faster battery exchange. The company says its automated battery swap stations take only three minutes to produce a fully charged battery replacement.\nLooking ahead\nNIO's push into the luxury sedan segment with its ET7 could help advance the company to the next level. Gross margins, gross profit, and operating cash flow went positive in 2020, indicating the path to profitability is in sight.\nBoth companies look to be adequately capitalized to fund planned growth efforts. As of Dec. 31, 2020, NIO had $6.5 billion in cash and cash equivalents, restricted cash, and short-term investment on its balance sheet, and XPeng had about $5.4 billion. The companies could raise more money by listing on the Hong Kong Stock Exchange, which is reportedly being considered by both.\nFor investors looking to pick just one holding to participate in Chinese EV growth, NIO appears to be the better option of these two companies. Any investment still belongs in the speculative portion of a portfolio, with the potential for much volatility. But for those who can stomach that, and have an appropriate portion invested, the recent drop in shares helps make NIO a better buy than XPeng right now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":181,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":321707278,"gmtCreate":1615468165494,"gmtModify":1704783154452,"author":{"id":"3575445316557349","authorId":"3575445316557349","name":"FlexK","avatar":"https://static.tigerbbs.com/5218345f4899882a5ef1356407aa5eb5","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"???","listText":"???","text":"???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/321707278","repostId":"1195977229","repostType":4,"repost":{"id":"1195977229","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1615467127,"share":"https://www.laohu8.com/m/news/1195977229?lang=&edition=full","pubTime":"2021-03-11 20:52","market":"us","language":"en","title":"Toplines Before US Market Open on Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=1195977229","media":"Tiger Newspress","summary":"U.S. stock futures rose on Thursday10-year rate below 1.5%Jobless claims data In focusU.S. stock fut","content":"<ul><li>U.S. stock futures rose on Thursday</li></ul><ul><li>10-year rate below 1.5%</li></ul><ul><li>Jobless claims data In focus</li></ul><p>U.S. stock futures rose on Thursday after the market’s blue-chip average set another record high a day earlier.</p><p>Futures contracts for the Dow Jones Industrial Average added 96 points, or 0.3%. S&P 500 futures climbed 0.7%.The big winner, however, was the tech-heavy Nasdaq 100 with futures jumping 1.6%.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/02dd3f7c429e192a4843f11763cbe0b4\" tg-width=\"1080\" tg-height=\"391\" referrerpolicy=\"no-referrer\"><span>*Source From Tiger Trade, EST 07:30</span></p><p>A rotation back into tech shares appeared to be happening early Thursday. Tesla was up 4% in premarket trading. Nvidia and Apple shares were also higher.while GameStop Corp. sank 4% in the premarket after a wild day of volatility.</p><p><img src=\"https://static.tigerbbs.com/0b9f5e6f6361ad3cc7ef5fb8cbab9587\" tg-width=\"417\" tg-height=\"430\" referrerpolicy=\"no-referrer\"></p><p>The 10-year Treasury yield slide for a second day, helping sentiment. The 10-year yield was last down about 2 basis pints to 1.50%. (1 basis point is 0.01%)</p><p>Weekly jobless claims data is due out at 8:30 a.m. ET on Thursday, with economists surveyed by Dow Jones expecting 725,000 new claims.</p><p>Data showing the number of job openings in January is expected to be released at 10 a.m. ET.</p><p><b>Stocks making the biggest moves premarket</b></p><p>AMC Entertainment(AMC) – AMC stock jumped 6% premarket after it said the Covid-19 vaccine rollout and upcoming major releases would boost movie theater ticket sales this year. That followed a quarterly loss that nonetheless saw better-than-expected revenue. AMC said 8 million patrons returned to its theaters during the most recent quarter.</p><p>JD.com(JD) – The China-based e-commerce company saw its shares rise 7.9% premarket after it reported better-than-expected profit and revenue for its latest quarter. It gained shoppers even as China largely emerged from coronavirus lockdowns.</p><p>Bilibili(BILI) – The China-based online entertainment platform's shares jumped 7.5% premarket following news that it won approval from the Hong Kong Stock Exchange to list its shares.</p><p>Roblox(RBLX) – The videogame platform company’s shares rose another 10.2% today, following gains during its Wednesday Wall Street debut that raised its total market valuation to about $45 billion.The $7.1 billion ARK Next Generation Internet exchange-traded fund (ticker ARKW) purchased more than 500,000 Roblox shares, according to the latest data on Ark’s website. The New York-based firm lists the market value of the stake as a little over $36 million.</p><p>Oracle(ORCL) – Oracle reported an adjusted quarterly profit of $1.16 per share, 5 cents above estimates, and the business software giant’s revenue was slightly above Wall Street forecasts. However, revenue in Oracle’s cloud division fell short of analyst projections, and Oracle shares fell 5.4% premarket. Oracle also increased its dividend by 33% and increased its share buyback program by $20 billion.</p><p>Boeing(BA) – Boeing is close to finalizing a multi-billion dollar order for its 737 MAX jets from Southwest Airlines(LUV), according to people familiar with the matter who spoke to Reuters. It would be the largest order for the MAX since it was ungrounded, and also would stave off a possible defection to rival Airbus by Southwest, which had been the largest customer for the 737 MAX prior to the grounding. Boeing rose 2.1% premarket.</p><p>Bumble(BMBL) – Bumble beat Wall Street’s revenue estimates in its first quarter as a public company, and gave an upbeat projection for the current quarter. The dating service company said it expects pent-up demand from people who had been reluctant to date during the pandemic. Bumble shares surged 9% premarket.</p><p>Cloudera(CLDR) – Cloudera beat estimates by 4 cents with adjusted quarterly earnings of 15 cents per share, and revenue above estimates as well. However, the data cloud company also gave weaker-than-expected forecasts for both profit and revenue, and its shares tumbled 7% premarket.</p><p>AstraZeneca(AZN) – Denmark temporarily suspended the use of AstraZeneca’s Covid-19 vaccine following reported cases of blood clots formed in patients. The suspension will last for 14 days while regulators investigate. AstraZeneca said it maintains strict quality controls and that there had been no serious adverse events associated with the vaccine. AstraZeneca lost 1.9% in premarket trading.</p><p>Coupang(CPNG) – Coupang makes its Wall Street debut today after the South Korean e-commerce company priced its initial public offering of 130 million shares at $35 per share, above the expected range of $32 to $34. Coupang raised $4.6 billion in the largest U.S. IPO so far this year.</p><p>Vir Biotechnology(VIR),GlaxoSmithKline(GSK) – Vir and Glaxo said their Covid-19 antibody treatment reduced hospitalizations and death from the disease by 85% in a clinical trial. The drug makers said they will immediately seek emergency use authorization for the drug in the U.S. and other countries. Vir shares soared 60% premarket.</p><p>MSG Networks(MSGN) – MSG Networks is considering merging withMadison Square Garden Entertainment(MSGE), according to people familiar with the matter who spoke to Bloomberg. Such a deal would reverse a prior split of the two entities. MSG Networks jumped 4.6% premarket, while Madison Square Garden Entertainment jumped 7.4%.</p><p>Party City(PRTY) – Party City shares tumbled 10% premarket after the party supplies retailer reported quarterly earnings of 25 cents per share, missing forecasts by 6 cents. Party City’s revenue matched Wall Street forecasts, but its same-store sales decline of 5.9% was slightly larger than the Refinitiv consensus estimate of a 5.2% decline.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Thursday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Thursday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-03-11 20:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul><li>U.S. stock futures rose on Thursday</li></ul><ul><li>10-year rate below 1.5%</li></ul><ul><li>Jobless claims data In focus</li></ul><p>U.S. stock futures rose on Thursday after the market’s blue-chip average set another record high a day earlier.</p><p>Futures contracts for the Dow Jones Industrial Average added 96 points, or 0.3%. S&P 500 futures climbed 0.7%.The big winner, however, was the tech-heavy Nasdaq 100 with futures jumping 1.6%.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/02dd3f7c429e192a4843f11763cbe0b4\" tg-width=\"1080\" tg-height=\"391\" referrerpolicy=\"no-referrer\"><span>*Source From Tiger Trade, EST 07:30</span></p><p>A rotation back into tech shares appeared to be happening early Thursday. Tesla was up 4% in premarket trading. Nvidia and Apple shares were also higher.while GameStop Corp. sank 4% in the premarket after a wild day of volatility.</p><p><img src=\"https://static.tigerbbs.com/0b9f5e6f6361ad3cc7ef5fb8cbab9587\" tg-width=\"417\" tg-height=\"430\" referrerpolicy=\"no-referrer\"></p><p>The 10-year Treasury yield slide for a second day, helping sentiment. The 10-year yield was last down about 2 basis pints to 1.50%. (1 basis point is 0.01%)</p><p>Weekly jobless claims data is due out at 8:30 a.m. ET on Thursday, with economists surveyed by Dow Jones expecting 725,000 new claims.</p><p>Data showing the number of job openings in January is expected to be released at 10 a.m. ET.</p><p><b>Stocks making the biggest moves premarket</b></p><p>AMC Entertainment(AMC) – AMC stock jumped 6% premarket after it said the Covid-19 vaccine rollout and upcoming major releases would boost movie theater ticket sales this year. That followed a quarterly loss that nonetheless saw better-than-expected revenue. AMC said 8 million patrons returned to its theaters during the most recent quarter.</p><p>JD.com(JD) – The China-based e-commerce company saw its shares rise 7.9% premarket after it reported better-than-expected profit and revenue for its latest quarter. It gained shoppers even as China largely emerged from coronavirus lockdowns.</p><p>Bilibili(BILI) – The China-based online entertainment platform's shares jumped 7.5% premarket following news that it won approval from the Hong Kong Stock Exchange to list its shares.</p><p>Roblox(RBLX) – The videogame platform company’s shares rose another 10.2% today, following gains during its Wednesday Wall Street debut that raised its total market valuation to about $45 billion.The $7.1 billion ARK Next Generation Internet exchange-traded fund (ticker ARKW) purchased more than 500,000 Roblox shares, according to the latest data on Ark’s website. The New York-based firm lists the market value of the stake as a little over $36 million.</p><p>Oracle(ORCL) – Oracle reported an adjusted quarterly profit of $1.16 per share, 5 cents above estimates, and the business software giant’s revenue was slightly above Wall Street forecasts. However, revenue in Oracle’s cloud division fell short of analyst projections, and Oracle shares fell 5.4% premarket. Oracle also increased its dividend by 33% and increased its share buyback program by $20 billion.</p><p>Boeing(BA) – Boeing is close to finalizing a multi-billion dollar order for its 737 MAX jets from Southwest Airlines(LUV), according to people familiar with the matter who spoke to Reuters. It would be the largest order for the MAX since it was ungrounded, and also would stave off a possible defection to rival Airbus by Southwest, which had been the largest customer for the 737 MAX prior to the grounding. Boeing rose 2.1% premarket.</p><p>Bumble(BMBL) – Bumble beat Wall Street’s revenue estimates in its first quarter as a public company, and gave an upbeat projection for the current quarter. The dating service company said it expects pent-up demand from people who had been reluctant to date during the pandemic. Bumble shares surged 9% premarket.</p><p>Cloudera(CLDR) – Cloudera beat estimates by 4 cents with adjusted quarterly earnings of 15 cents per share, and revenue above estimates as well. However, the data cloud company also gave weaker-than-expected forecasts for both profit and revenue, and its shares tumbled 7% premarket.</p><p>AstraZeneca(AZN) – Denmark temporarily suspended the use of AstraZeneca’s Covid-19 vaccine following reported cases of blood clots formed in patients. The suspension will last for 14 days while regulators investigate. AstraZeneca said it maintains strict quality controls and that there had been no serious adverse events associated with the vaccine. AstraZeneca lost 1.9% in premarket trading.</p><p>Coupang(CPNG) – Coupang makes its Wall Street debut today after the South Korean e-commerce company priced its initial public offering of 130 million shares at $35 per share, above the expected range of $32 to $34. Coupang raised $4.6 billion in the largest U.S. IPO so far this year.</p><p>Vir Biotechnology(VIR),GlaxoSmithKline(GSK) – Vir and Glaxo said their Covid-19 antibody treatment reduced hospitalizations and death from the disease by 85% in a clinical trial. The drug makers said they will immediately seek emergency use authorization for the drug in the U.S. and other countries. Vir shares soared 60% premarket.</p><p>MSG Networks(MSGN) – MSG Networks is considering merging withMadison Square Garden Entertainment(MSGE), according to people familiar with the matter who spoke to Bloomberg. Such a deal would reverse a prior split of the two entities. MSG Networks jumped 4.6% premarket, while Madison Square Garden Entertainment jumped 7.4%.</p><p>Party City(PRTY) – Party City shares tumbled 10% premarket after the party supplies retailer reported quarterly earnings of 25 cents per share, missing forecasts by 6 cents. Party City’s revenue matched Wall Street forecasts, but its same-store sales decline of 5.9% was slightly larger than the Refinitiv consensus estimate of a 5.2% decline.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线","GME":"游戏驿站","AAPL":"苹果","JD":"京东"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195977229","content_text":"U.S. stock futures rose on Thursday10-year rate below 1.5%Jobless claims data In focusU.S. stock futures rose on Thursday after the market’s blue-chip average set another record high a day earlier.Futures contracts for the Dow Jones Industrial Average added 96 points, or 0.3%. S&P 500 futures climbed 0.7%.The big winner, however, was the tech-heavy Nasdaq 100 with futures jumping 1.6%.*Source From Tiger Trade, EST 07:30A rotation back into tech shares appeared to be happening early Thursday. Tesla was up 4% in premarket trading. Nvidia and Apple shares were also higher.while GameStop Corp. sank 4% in the premarket after a wild day of volatility.The 10-year Treasury yield slide for a second day, helping sentiment. The 10-year yield was last down about 2 basis pints to 1.50%. (1 basis point is 0.01%)Weekly jobless claims data is due out at 8:30 a.m. ET on Thursday, with economists surveyed by Dow Jones expecting 725,000 new claims.Data showing the number of job openings in January is expected to be released at 10 a.m. ET.Stocks making the biggest moves premarketAMC Entertainment(AMC) – AMC stock jumped 6% premarket after it said the Covid-19 vaccine rollout and upcoming major releases would boost movie theater ticket sales this year. That followed a quarterly loss that nonetheless saw better-than-expected revenue. AMC said 8 million patrons returned to its theaters during the most recent quarter.JD.com(JD) – The China-based e-commerce company saw its shares rise 7.9% premarket after it reported better-than-expected profit and revenue for its latest quarter. It gained shoppers even as China largely emerged from coronavirus lockdowns.Bilibili(BILI) – The China-based online entertainment platform's shares jumped 7.5% premarket following news that it won approval from the Hong Kong Stock Exchange to list its shares.Roblox(RBLX) – The videogame platform company’s shares rose another 10.2% today, following gains during its Wednesday Wall Street debut that raised its total market valuation to about $45 billion.The $7.1 billion ARK Next Generation Internet exchange-traded fund (ticker ARKW) purchased more than 500,000 Roblox shares, according to the latest data on Ark’s website. The New York-based firm lists the market value of the stake as a little over $36 million.Oracle(ORCL) – Oracle reported an adjusted quarterly profit of $1.16 per share, 5 cents above estimates, and the business software giant’s revenue was slightly above Wall Street forecasts. However, revenue in Oracle’s cloud division fell short of analyst projections, and Oracle shares fell 5.4% premarket. Oracle also increased its dividend by 33% and increased its share buyback program by $20 billion.Boeing(BA) – Boeing is close to finalizing a multi-billion dollar order for its 737 MAX jets from Southwest Airlines(LUV), according to people familiar with the matter who spoke to Reuters. It would be the largest order for the MAX since it was ungrounded, and also would stave off a possible defection to rival Airbus by Southwest, which had been the largest customer for the 737 MAX prior to the grounding. Boeing rose 2.1% premarket.Bumble(BMBL) – Bumble beat Wall Street’s revenue estimates in its first quarter as a public company, and gave an upbeat projection for the current quarter. The dating service company said it expects pent-up demand from people who had been reluctant to date during the pandemic. Bumble shares surged 9% premarket.Cloudera(CLDR) – Cloudera beat estimates by 4 cents with adjusted quarterly earnings of 15 cents per share, and revenue above estimates as well. However, the data cloud company also gave weaker-than-expected forecasts for both profit and revenue, and its shares tumbled 7% premarket.AstraZeneca(AZN) – Denmark temporarily suspended the use of AstraZeneca’s Covid-19 vaccine following reported cases of blood clots formed in patients. The suspension will last for 14 days while regulators investigate. AstraZeneca said it maintains strict quality controls and that there had been no serious adverse events associated with the vaccine. AstraZeneca lost 1.9% in premarket trading.Coupang(CPNG) – Coupang makes its Wall Street debut today after the South Korean e-commerce company priced its initial public offering of 130 million shares at $35 per share, above the expected range of $32 to $34. Coupang raised $4.6 billion in the largest U.S. IPO so far this year.Vir Biotechnology(VIR),GlaxoSmithKline(GSK) – Vir and Glaxo said their Covid-19 antibody treatment reduced hospitalizations and death from the disease by 85% in a clinical trial. The drug makers said they will immediately seek emergency use authorization for the drug in the U.S. and other countries. Vir shares soared 60% premarket.MSG Networks(MSGN) – MSG Networks is considering merging withMadison Square Garden Entertainment(MSGE), according to people familiar with the matter who spoke to Bloomberg. Such a deal would reverse a prior split of the two entities. MSG Networks jumped 4.6% premarket, while Madison Square Garden Entertainment jumped 7.4%.Party City(PRTY) – Party City shares tumbled 10% premarket after the party supplies retailer reported quarterly earnings of 25 cents per share, missing forecasts by 6 cents. Party City’s revenue matched Wall Street forecasts, but its same-store sales decline of 5.9% was slightly larger than the Refinitiv consensus estimate of a 5.2% decline.","news_type":1},"isVote":1,"tweetType":1,"viewCount":208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":322132524,"gmtCreate":1615781774768,"gmtModify":1704786399525,"author":{"id":"3575445316557349","authorId":"3575445316557349","name":"FlexK","avatar":"https://static.tigerbbs.com/5218345f4899882a5ef1356407aa5eb5","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"NIO go","listText":"NIO go","text":"NIO go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/322132524","repostId":"1161179297","repostType":4,"repost":{"id":"1161179297","pubTimestamp":1615771321,"share":"https://www.laohu8.com/m/news/1161179297?lang=&edition=full","pubTime":"2021-03-15 09:22","market":"us","language":"en","title":"Better Buy: NIO vs. XPeng Motors","url":"https://stock-news.laohu8.com/highlight/detail?id=1161179297","media":"Motley Fool","summary":"The Chinese electric-vehicle makers both have rich valuations, even after a downturn in share prices.Stocks of electric-vehicle makers accelerated in 2020. And it's no secret that Chinese EV stocks were some of the most popular, as the largest automotive market in the world continues to move toward electrification in its transportation sector.EV sales in China surpassed 1 million in 2020, and the government hopes to grow that to 5 million by 2025. It could reach 10 million by 2030, and approach","content":"<p>The Chinese electric-vehicle makers both have rich valuations, even after a downturn in share prices.</p>\n<p>Stocks of electric-vehicle (EV) makers accelerated in 2020. And it's no secret that Chinese EV stocks were some of the most popular, as the largest automotive market in the world continues to move toward electrification in its transportation sector.</p>\n<p>EV sales in China surpassed 1 million in 2020, and the government hopes to grow that to 5 million by 2025. It could reach 10 million by 2030, and approach 20 million by 2040, according to research organization BloombergNEF. Two electric automakers looking to capitalize on that expansion are <b>NIO</b> (NYSE:NIO) and <b>XPeng</b> (NYSE:XPEV). Investors may be wondering which is the better buy, particularly after a correction has hit share prices in the sector.</p>\n<p><b>The right market</b></p>\n<p>As noted above, the largest automotive market in the world has much potential forEV growth. The problem is, there will be plenty of companies seeking to capitalize.<b>Tesla</b> (NASDAQ:TSLA) built its second manufacturing plant in Shanghai for a reason. And though they're maybe the most well-known Chinese EV makers, NIO and XPeng combined delivered only slightly more than half the 131,000 battery-electric vehicles that <b>BYD</b> (OTC:BYDDY) sold in 2020.</p>\n<p>NIO reached almost 44,000 vehicles delivered in 2020, while XPeng more than doubled its volume versus 2019 to 27,041. Both companies have recently introduced sedan models that each hopes will be significant drivers of future sales growth.</p>\n<p>XPeng's P7 sports sedan has surpassed a total of 20,000 cumulative deliveries since its launch in early 2020, as it moves ahead of the G3 compact SUV as the company's most popular vehicle. That marked the fastest pace to 20,000 vehicle deliveries of any Chinese EV start-up.</p>\n<p>NIO introduced its new ET7 luxury sedan earlier this year. The ET7 will be available early next year, and has some intricate features. The sleek exterior includes autonomous driving sensors, a \"crystal-like heartbeat\" tail light, all-glass roof, and a digital entry system that extends the flush handle and automatically releases the door's \"e-latch\" as the driver approaches.</p>\n<p><b>Priced for perfection</b></p>\n<p>The strong sales growth along with massive potential for Chinese EVs had investors already piling into these stocks. But after shares of both NIO and XPeng soared last year, the stocks are off January 2021 highs by 27% and 38% respectively, making now a good time to see which may be the better buy.</p>\n<p>Neither company is profitable yet, so one way to measure valuations is using sales rather than earnings. The price-to-sales ratios (P/S) are both very high, but sales are expected to grow quickly, and it's a relevant metric for comparing the two companies.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/cf721bd77e4fa0e2530b3d2f86034920\" tg-width=\"720\" tg-height=\"483\"><span>NIO MARKET CAP DATA BY YCHARTS</span></p>\n<p>Though NIO has the higher market cap, it is less expensive than XPeng as measured by the P/S ratio. NIO also has a unique approach to the market with its battery swap program, which allows customers to \"recharge\" via a faster battery exchange. The company says its automated battery swap stations take only three minutes to produce a fully charged battery replacement.</p>\n<p><b>Looking ahead</b></p>\n<p>NIO's push into the luxury sedan segment with its ET7 could help advance the company to the next level. Gross margins, gross profit, and operating cash flow went positive in 2020, indicating the path to profitability is in sight.</p>\n<p>Both companies look to be adequately capitalized to fund planned growth efforts. As of Dec. 31, 2020, NIO had $6.5 billion in cash and cash equivalents, restricted cash, and short-term investment on its balance sheet, and XPeng had about $5.4 billion. The companies could raise more money by listing on the Hong Kong Stock Exchange, which is reportedly being considered by both.</p>\n<p>For investors looking to pick just one holding to participate in Chinese EV growth, NIO appears to be the better option of these two companies. Any investment still belongs in the speculative portion of a portfolio, with the potential for much volatility. But for those who can stomach that, and have an appropriate portion invested, the recent drop in shares helps make NIO a better buy than XPeng right now.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Better Buy: NIO vs. XPeng Motors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBetter Buy: NIO vs. XPeng Motors\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-15 09:22 GMT+8 <a href=https://www.fool.com/investing/2021/03/14/better-buy-nio-vs-xpeng-motors/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Chinese electric-vehicle makers both have rich valuations, even after a downturn in share prices.\nStocks of electric-vehicle (EV) makers accelerated in 2020. And it's no secret that Chinese EV ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/14/better-buy-nio-vs-xpeng-motors/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来","XPEV":"小鹏汽车"},"source_url":"https://www.fool.com/investing/2021/03/14/better-buy-nio-vs-xpeng-motors/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161179297","content_text":"The Chinese electric-vehicle makers both have rich valuations, even after a downturn in share prices.\nStocks of electric-vehicle (EV) makers accelerated in 2020. And it's no secret that Chinese EV stocks were some of the most popular, as the largest automotive market in the world continues to move toward electrification in its transportation sector.\nEV sales in China surpassed 1 million in 2020, and the government hopes to grow that to 5 million by 2025. It could reach 10 million by 2030, and approach 20 million by 2040, according to research organization BloombergNEF. Two electric automakers looking to capitalize on that expansion are NIO (NYSE:NIO) and XPeng (NYSE:XPEV). Investors may be wondering which is the better buy, particularly after a correction has hit share prices in the sector.\nThe right market\nAs noted above, the largest automotive market in the world has much potential forEV growth. The problem is, there will be plenty of companies seeking to capitalize.Tesla (NASDAQ:TSLA) built its second manufacturing plant in Shanghai for a reason. And though they're maybe the most well-known Chinese EV makers, NIO and XPeng combined delivered only slightly more than half the 131,000 battery-electric vehicles that BYD (OTC:BYDDY) sold in 2020.\nNIO reached almost 44,000 vehicles delivered in 2020, while XPeng more than doubled its volume versus 2019 to 27,041. Both companies have recently introduced sedan models that each hopes will be significant drivers of future sales growth.\nXPeng's P7 sports sedan has surpassed a total of 20,000 cumulative deliveries since its launch in early 2020, as it moves ahead of the G3 compact SUV as the company's most popular vehicle. That marked the fastest pace to 20,000 vehicle deliveries of any Chinese EV start-up.\nNIO introduced its new ET7 luxury sedan earlier this year. The ET7 will be available early next year, and has some intricate features. The sleek exterior includes autonomous driving sensors, a \"crystal-like heartbeat\" tail light, all-glass roof, and a digital entry system that extends the flush handle and automatically releases the door's \"e-latch\" as the driver approaches.\nPriced for perfection\nThe strong sales growth along with massive potential for Chinese EVs had investors already piling into these stocks. But after shares of both NIO and XPeng soared last year, the stocks are off January 2021 highs by 27% and 38% respectively, making now a good time to see which may be the better buy.\nNeither company is profitable yet, so one way to measure valuations is using sales rather than earnings. The price-to-sales ratios (P/S) are both very high, but sales are expected to grow quickly, and it's a relevant metric for comparing the two companies.\nNIO MARKET CAP DATA BY YCHARTS\nThough NIO has the higher market cap, it is less expensive than XPeng as measured by the P/S ratio. NIO also has a unique approach to the market with its battery swap program, which allows customers to \"recharge\" via a faster battery exchange. The company says its automated battery swap stations take only three minutes to produce a fully charged battery replacement.\nLooking ahead\nNIO's push into the luxury sedan segment with its ET7 could help advance the company to the next level. Gross margins, gross profit, and operating cash flow went positive in 2020, indicating the path to profitability is in sight.\nBoth companies look to be adequately capitalized to fund planned growth efforts. As of Dec. 31, 2020, NIO had $6.5 billion in cash and cash equivalents, restricted cash, and short-term investment on its balance sheet, and XPeng had about $5.4 billion. The companies could raise more money by listing on the Hong Kong Stock Exchange, which is reportedly being considered by both.\nFor investors looking to pick just one holding to participate in Chinese EV growth, NIO appears to be the better option of these two companies. Any investment still belongs in the speculative portion of a portfolio, with the potential for much volatility. But for those who can stomach that, and have an appropriate portion invested, the recent drop in shares helps make NIO a better buy than XPeng right now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":181,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":321707278,"gmtCreate":1615468165494,"gmtModify":1704783154452,"author":{"id":"3575445316557349","authorId":"3575445316557349","name":"FlexK","avatar":"https://static.tigerbbs.com/5218345f4899882a5ef1356407aa5eb5","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"???","listText":"???","text":"???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/321707278","repostId":"1195977229","repostType":4,"repost":{"id":"1195977229","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1615467127,"share":"https://www.laohu8.com/m/news/1195977229?lang=&edition=full","pubTime":"2021-03-11 20:52","market":"us","language":"en","title":"Toplines Before US Market Open on Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=1195977229","media":"Tiger Newspress","summary":"U.S. stock futures rose on Thursday10-year rate below 1.5%Jobless claims data In focusU.S. stock fut","content":"<ul><li>U.S. stock futures rose on Thursday</li></ul><ul><li>10-year rate below 1.5%</li></ul><ul><li>Jobless claims data In focus</li></ul><p>U.S. stock futures rose on Thursday after the market’s blue-chip average set another record high a day earlier.</p><p>Futures contracts for the Dow Jones Industrial Average added 96 points, or 0.3%. S&P 500 futures climbed 0.7%.The big winner, however, was the tech-heavy Nasdaq 100 with futures jumping 1.6%.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/02dd3f7c429e192a4843f11763cbe0b4\" tg-width=\"1080\" tg-height=\"391\" referrerpolicy=\"no-referrer\"><span>*Source From Tiger Trade, EST 07:30</span></p><p>A rotation back into tech shares appeared to be happening early Thursday. Tesla was up 4% in premarket trading. Nvidia and Apple shares were also higher.while GameStop Corp. sank 4% in the premarket after a wild day of volatility.</p><p><img src=\"https://static.tigerbbs.com/0b9f5e6f6361ad3cc7ef5fb8cbab9587\" tg-width=\"417\" tg-height=\"430\" referrerpolicy=\"no-referrer\"></p><p>The 10-year Treasury yield slide for a second day, helping sentiment. The 10-year yield was last down about 2 basis pints to 1.50%. (1 basis point is 0.01%)</p><p>Weekly jobless claims data is due out at 8:30 a.m. ET on Thursday, with economists surveyed by Dow Jones expecting 725,000 new claims.</p><p>Data showing the number of job openings in January is expected to be released at 10 a.m. ET.</p><p><b>Stocks making the biggest moves premarket</b></p><p>AMC Entertainment(AMC) – AMC stock jumped 6% premarket after it said the Covid-19 vaccine rollout and upcoming major releases would boost movie theater ticket sales this year. That followed a quarterly loss that nonetheless saw better-than-expected revenue. AMC said 8 million patrons returned to its theaters during the most recent quarter.</p><p>JD.com(JD) – The China-based e-commerce company saw its shares rise 7.9% premarket after it reported better-than-expected profit and revenue for its latest quarter. It gained shoppers even as China largely emerged from coronavirus lockdowns.</p><p>Bilibili(BILI) – The China-based online entertainment platform's shares jumped 7.5% premarket following news that it won approval from the Hong Kong Stock Exchange to list its shares.</p><p>Roblox(RBLX) – The videogame platform company’s shares rose another 10.2% today, following gains during its Wednesday Wall Street debut that raised its total market valuation to about $45 billion.The $7.1 billion ARK Next Generation Internet exchange-traded fund (ticker ARKW) purchased more than 500,000 Roblox shares, according to the latest data on Ark’s website. The New York-based firm lists the market value of the stake as a little over $36 million.</p><p>Oracle(ORCL) – Oracle reported an adjusted quarterly profit of $1.16 per share, 5 cents above estimates, and the business software giant’s revenue was slightly above Wall Street forecasts. However, revenue in Oracle’s cloud division fell short of analyst projections, and Oracle shares fell 5.4% premarket. Oracle also increased its dividend by 33% and increased its share buyback program by $20 billion.</p><p>Boeing(BA) – Boeing is close to finalizing a multi-billion dollar order for its 737 MAX jets from Southwest Airlines(LUV), according to people familiar with the matter who spoke to Reuters. It would be the largest order for the MAX since it was ungrounded, and also would stave off a possible defection to rival Airbus by Southwest, which had been the largest customer for the 737 MAX prior to the grounding. Boeing rose 2.1% premarket.</p><p>Bumble(BMBL) – Bumble beat Wall Street’s revenue estimates in its first quarter as a public company, and gave an upbeat projection for the current quarter. The dating service company said it expects pent-up demand from people who had been reluctant to date during the pandemic. Bumble shares surged 9% premarket.</p><p>Cloudera(CLDR) – Cloudera beat estimates by 4 cents with adjusted quarterly earnings of 15 cents per share, and revenue above estimates as well. However, the data cloud company also gave weaker-than-expected forecasts for both profit and revenue, and its shares tumbled 7% premarket.</p><p>AstraZeneca(AZN) – Denmark temporarily suspended the use of AstraZeneca’s Covid-19 vaccine following reported cases of blood clots formed in patients. The suspension will last for 14 days while regulators investigate. AstraZeneca said it maintains strict quality controls and that there had been no serious adverse events associated with the vaccine. AstraZeneca lost 1.9% in premarket trading.</p><p>Coupang(CPNG) – Coupang makes its Wall Street debut today after the South Korean e-commerce company priced its initial public offering of 130 million shares at $35 per share, above the expected range of $32 to $34. Coupang raised $4.6 billion in the largest U.S. IPO so far this year.</p><p>Vir Biotechnology(VIR),GlaxoSmithKline(GSK) – Vir and Glaxo said their Covid-19 antibody treatment reduced hospitalizations and death from the disease by 85% in a clinical trial. The drug makers said they will immediately seek emergency use authorization for the drug in the U.S. and other countries. Vir shares soared 60% premarket.</p><p>MSG Networks(MSGN) – MSG Networks is considering merging withMadison Square Garden Entertainment(MSGE), according to people familiar with the matter who spoke to Bloomberg. Such a deal would reverse a prior split of the two entities. MSG Networks jumped 4.6% premarket, while Madison Square Garden Entertainment jumped 7.4%.</p><p>Party City(PRTY) – Party City shares tumbled 10% premarket after the party supplies retailer reported quarterly earnings of 25 cents per share, missing forecasts by 6 cents. Party City’s revenue matched Wall Street forecasts, but its same-store sales decline of 5.9% was slightly larger than the Refinitiv consensus estimate of a 5.2% decline.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Thursday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Thursday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-03-11 20:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul><li>U.S. stock futures rose on Thursday</li></ul><ul><li>10-year rate below 1.5%</li></ul><ul><li>Jobless claims data In focus</li></ul><p>U.S. stock futures rose on Thursday after the market’s blue-chip average set another record high a day earlier.</p><p>Futures contracts for the Dow Jones Industrial Average added 96 points, or 0.3%. S&P 500 futures climbed 0.7%.The big winner, however, was the tech-heavy Nasdaq 100 with futures jumping 1.6%.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/02dd3f7c429e192a4843f11763cbe0b4\" tg-width=\"1080\" tg-height=\"391\" referrerpolicy=\"no-referrer\"><span>*Source From Tiger Trade, EST 07:30</span></p><p>A rotation back into tech shares appeared to be happening early Thursday. Tesla was up 4% in premarket trading. Nvidia and Apple shares were also higher.while GameStop Corp. sank 4% in the premarket after a wild day of volatility.</p><p><img src=\"https://static.tigerbbs.com/0b9f5e6f6361ad3cc7ef5fb8cbab9587\" tg-width=\"417\" tg-height=\"430\" referrerpolicy=\"no-referrer\"></p><p>The 10-year Treasury yield slide for a second day, helping sentiment. The 10-year yield was last down about 2 basis pints to 1.50%. (1 basis point is 0.01%)</p><p>Weekly jobless claims data is due out at 8:30 a.m. ET on Thursday, with economists surveyed by Dow Jones expecting 725,000 new claims.</p><p>Data showing the number of job openings in January is expected to be released at 10 a.m. ET.</p><p><b>Stocks making the biggest moves premarket</b></p><p>AMC Entertainment(AMC) – AMC stock jumped 6% premarket after it said the Covid-19 vaccine rollout and upcoming major releases would boost movie theater ticket sales this year. That followed a quarterly loss that nonetheless saw better-than-expected revenue. AMC said 8 million patrons returned to its theaters during the most recent quarter.</p><p>JD.com(JD) – The China-based e-commerce company saw its shares rise 7.9% premarket after it reported better-than-expected profit and revenue for its latest quarter. It gained shoppers even as China largely emerged from coronavirus lockdowns.</p><p>Bilibili(BILI) – The China-based online entertainment platform's shares jumped 7.5% premarket following news that it won approval from the Hong Kong Stock Exchange to list its shares.</p><p>Roblox(RBLX) – The videogame platform company’s shares rose another 10.2% today, following gains during its Wednesday Wall Street debut that raised its total market valuation to about $45 billion.The $7.1 billion ARK Next Generation Internet exchange-traded fund (ticker ARKW) purchased more than 500,000 Roblox shares, according to the latest data on Ark’s website. The New York-based firm lists the market value of the stake as a little over $36 million.</p><p>Oracle(ORCL) – Oracle reported an adjusted quarterly profit of $1.16 per share, 5 cents above estimates, and the business software giant’s revenue was slightly above Wall Street forecasts. However, revenue in Oracle’s cloud division fell short of analyst projections, and Oracle shares fell 5.4% premarket. Oracle also increased its dividend by 33% and increased its share buyback program by $20 billion.</p><p>Boeing(BA) – Boeing is close to finalizing a multi-billion dollar order for its 737 MAX jets from Southwest Airlines(LUV), according to people familiar with the matter who spoke to Reuters. It would be the largest order for the MAX since it was ungrounded, and also would stave off a possible defection to rival Airbus by Southwest, which had been the largest customer for the 737 MAX prior to the grounding. Boeing rose 2.1% premarket.</p><p>Bumble(BMBL) – Bumble beat Wall Street’s revenue estimates in its first quarter as a public company, and gave an upbeat projection for the current quarter. The dating service company said it expects pent-up demand from people who had been reluctant to date during the pandemic. Bumble shares surged 9% premarket.</p><p>Cloudera(CLDR) – Cloudera beat estimates by 4 cents with adjusted quarterly earnings of 15 cents per share, and revenue above estimates as well. However, the data cloud company also gave weaker-than-expected forecasts for both profit and revenue, and its shares tumbled 7% premarket.</p><p>AstraZeneca(AZN) – Denmark temporarily suspended the use of AstraZeneca’s Covid-19 vaccine following reported cases of blood clots formed in patients. The suspension will last for 14 days while regulators investigate. AstraZeneca said it maintains strict quality controls and that there had been no serious adverse events associated with the vaccine. AstraZeneca lost 1.9% in premarket trading.</p><p>Coupang(CPNG) – Coupang makes its Wall Street debut today after the South Korean e-commerce company priced its initial public offering of 130 million shares at $35 per share, above the expected range of $32 to $34. Coupang raised $4.6 billion in the largest U.S. IPO so far this year.</p><p>Vir Biotechnology(VIR),GlaxoSmithKline(GSK) – Vir and Glaxo said their Covid-19 antibody treatment reduced hospitalizations and death from the disease by 85% in a clinical trial. The drug makers said they will immediately seek emergency use authorization for the drug in the U.S. and other countries. Vir shares soared 60% premarket.</p><p>MSG Networks(MSGN) – MSG Networks is considering merging withMadison Square Garden Entertainment(MSGE), according to people familiar with the matter who spoke to Bloomberg. Such a deal would reverse a prior split of the two entities. MSG Networks jumped 4.6% premarket, while Madison Square Garden Entertainment jumped 7.4%.</p><p>Party City(PRTY) – Party City shares tumbled 10% premarket after the party supplies retailer reported quarterly earnings of 25 cents per share, missing forecasts by 6 cents. Party City’s revenue matched Wall Street forecasts, but its same-store sales decline of 5.9% was slightly larger than the Refinitiv consensus estimate of a 5.2% decline.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线","GME":"游戏驿站","AAPL":"苹果","JD":"京东"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195977229","content_text":"U.S. stock futures rose on Thursday10-year rate below 1.5%Jobless claims data In focusU.S. stock futures rose on Thursday after the market’s blue-chip average set another record high a day earlier.Futures contracts for the Dow Jones Industrial Average added 96 points, or 0.3%. S&P 500 futures climbed 0.7%.The big winner, however, was the tech-heavy Nasdaq 100 with futures jumping 1.6%.*Source From Tiger Trade, EST 07:30A rotation back into tech shares appeared to be happening early Thursday. Tesla was up 4% in premarket trading. Nvidia and Apple shares were also higher.while GameStop Corp. sank 4% in the premarket after a wild day of volatility.The 10-year Treasury yield slide for a second day, helping sentiment. The 10-year yield was last down about 2 basis pints to 1.50%. (1 basis point is 0.01%)Weekly jobless claims data is due out at 8:30 a.m. ET on Thursday, with economists surveyed by Dow Jones expecting 725,000 new claims.Data showing the number of job openings in January is expected to be released at 10 a.m. ET.Stocks making the biggest moves premarketAMC Entertainment(AMC) – AMC stock jumped 6% premarket after it said the Covid-19 vaccine rollout and upcoming major releases would boost movie theater ticket sales this year. That followed a quarterly loss that nonetheless saw better-than-expected revenue. AMC said 8 million patrons returned to its theaters during the most recent quarter.JD.com(JD) – The China-based e-commerce company saw its shares rise 7.9% premarket after it reported better-than-expected profit and revenue for its latest quarter. It gained shoppers even as China largely emerged from coronavirus lockdowns.Bilibili(BILI) – The China-based online entertainment platform's shares jumped 7.5% premarket following news that it won approval from the Hong Kong Stock Exchange to list its shares.Roblox(RBLX) – The videogame platform company’s shares rose another 10.2% today, following gains during its Wednesday Wall Street debut that raised its total market valuation to about $45 billion.The $7.1 billion ARK Next Generation Internet exchange-traded fund (ticker ARKW) purchased more than 500,000 Roblox shares, according to the latest data on Ark’s website. The New York-based firm lists the market value of the stake as a little over $36 million.Oracle(ORCL) – Oracle reported an adjusted quarterly profit of $1.16 per share, 5 cents above estimates, and the business software giant’s revenue was slightly above Wall Street forecasts. However, revenue in Oracle’s cloud division fell short of analyst projections, and Oracle shares fell 5.4% premarket. Oracle also increased its dividend by 33% and increased its share buyback program by $20 billion.Boeing(BA) – Boeing is close to finalizing a multi-billion dollar order for its 737 MAX jets from Southwest Airlines(LUV), according to people familiar with the matter who spoke to Reuters. It would be the largest order for the MAX since it was ungrounded, and also would stave off a possible defection to rival Airbus by Southwest, which had been the largest customer for the 737 MAX prior to the grounding. Boeing rose 2.1% premarket.Bumble(BMBL) – Bumble beat Wall Street’s revenue estimates in its first quarter as a public company, and gave an upbeat projection for the current quarter. The dating service company said it expects pent-up demand from people who had been reluctant to date during the pandemic. Bumble shares surged 9% premarket.Cloudera(CLDR) – Cloudera beat estimates by 4 cents with adjusted quarterly earnings of 15 cents per share, and revenue above estimates as well. However, the data cloud company also gave weaker-than-expected forecasts for both profit and revenue, and its shares tumbled 7% premarket.AstraZeneca(AZN) – Denmark temporarily suspended the use of AstraZeneca’s Covid-19 vaccine following reported cases of blood clots formed in patients. The suspension will last for 14 days while regulators investigate. AstraZeneca said it maintains strict quality controls and that there had been no serious adverse events associated with the vaccine. AstraZeneca lost 1.9% in premarket trading.Coupang(CPNG) – Coupang makes its Wall Street debut today after the South Korean e-commerce company priced its initial public offering of 130 million shares at $35 per share, above the expected range of $32 to $34. Coupang raised $4.6 billion in the largest U.S. IPO so far this year.Vir Biotechnology(VIR),GlaxoSmithKline(GSK) – Vir and Glaxo said their Covid-19 antibody treatment reduced hospitalizations and death from the disease by 85% in a clinical trial. The drug makers said they will immediately seek emergency use authorization for the drug in the U.S. and other countries. Vir shares soared 60% premarket.MSG Networks(MSGN) – MSG Networks is considering merging withMadison Square Garden Entertainment(MSGE), according to people familiar with the matter who spoke to Bloomberg. Such a deal would reverse a prior split of the two entities. MSG Networks jumped 4.6% premarket, while Madison Square Garden Entertainment jumped 7.4%.Party City(PRTY) – Party City shares tumbled 10% premarket after the party supplies retailer reported quarterly earnings of 25 cents per share, missing forecasts by 6 cents. Party City’s revenue matched Wall Street forecasts, but its same-store sales decline of 5.9% was slightly larger than the Refinitiv consensus estimate of a 5.2% decline.","news_type":1},"isVote":1,"tweetType":1,"viewCount":208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":106493859,"gmtCreate":1620137561771,"gmtModify":1704339180265,"author":{"id":"3575445316557349","authorId":"3575445316557349","name":"FlexK","avatar":"https://static.tigerbbs.com/5218345f4899882a5ef1356407aa5eb5","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Dropping down trend","listText":"Dropping down trend","text":"Dropping down trend","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/106493859","repostId":"1157490418","repostType":4,"repost":{"id":"1157490418","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1620120727,"share":"https://www.laohu8.com/m/news/1157490418?lang=&edition=full","pubTime":"2021-05-04 17:32","market":"us","language":"en","title":"After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1157490418","media":"Tiger Newspress","summary":"(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.What happenedShares ","content":"<p style=\"text-align:left;\">(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.</p><p><img src=\"https://static.tigerbbs.com/231cd8867b2a322ce48be7afd711946c\" tg-width=\"633\" tg-height=\"479\" referrerpolicy=\"no-referrer\"><b>What happened</b></p><p>Shares of <b>Ocugen</b>(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.</p><p><b>So what</b></p><p>Researchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.</p><p>\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"</p><p><b>Now what</b></p><p>Musunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter surging nearly 24% yesterday, OCGN dipped 4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-05-04 17:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p style=\"text-align:left;\">(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.</p><p><img src=\"https://static.tigerbbs.com/231cd8867b2a322ce48be7afd711946c\" tg-width=\"633\" tg-height=\"479\" referrerpolicy=\"no-referrer\"><b>What happened</b></p><p>Shares of <b>Ocugen</b>(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.</p><p><b>So what</b></p><p>Researchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.</p><p>\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"</p><p><b>Now what</b></p><p>Musunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157490418","content_text":"(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.What happenedShares of Ocugen(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.So whatResearchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"Now whatMusunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.","news_type":1},"isVote":1,"tweetType":1,"viewCount":191,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}
